Your browser doesn't support javascript.
loading
VcR-CVAD Induction Chemotherapy Followed by Maintenance Rituximab Produces Durable Remissions in Mantle Cell Lymphoma: A Wisconsin Oncology Network Study.
Chang, Julie E; Carmichael, Lakeesha L; Kim, KyungMann; Peterson, Christopher; Yang, David T; Traynor, Anne M; Werndli, Jae E; Huie, Michael S; McFarland, Thomas A; Volk, Michael; Blank, Jules; Callander, Natalie S; Longo, Walter L; Kahl, Brad S.
Afiliação
  • Chang JE; Department of Medicine, University of Wisconsin School of Medicine and Public Health and the UW Carbone Cancer Center, Madison, WI. Electronic address: jc2@medicine.wisc.edu.
  • Carmichael LL; Department of Biostatistics and Medical Informatics, University of Wisconsin, Madison, WI.
  • Kim K; Department of Biostatistics and Medical Informatics, University of Wisconsin, Madison, WI.
  • Peterson C; Department of Hematology/Oncology, Aspirus Cancer Center, Wausau, WI.
  • Yang DT; Department of Pathology, University of Wisconsin School of Medicine and Public Health, Madison, WI.
  • Traynor AM; Department of Medicine, University of Wisconsin School of Medicine and Public Health and the UW Carbone Cancer Center, Madison, WI.
  • Werndli JE; Department of Medicine, University of Wisconsin Carbone Cancer Center, Madison, WI.
  • Huie MS; Department of Medicine, University of Wisconsin School of Medicine and Public Health and the UW Carbone Cancer Center, Madison, WI.
  • McFarland TA; Department of Medicine, University of Wisconsin School of Medicine and Public Health and the UW Carbone Cancer Center, Madison, WI.
  • Volk M; Department of Hematology/Oncology, Saint Vincent Regional Cancer Center, Green Bay, WI.
  • Blank J; Department of Hematology/Oncology, Saint Vincent Regional Cancer Center, Green Bay, WI.
  • Callander NS; Department of Medicine, University of Wisconsin School of Medicine and Public Health and the UW Carbone Cancer Center, Madison, WI.
  • Longo WL; Department of Medicine, University of Wisconsin School of Medicine and Public Health and the UW Carbone Cancer Center, Madison, WI.
  • Kahl BS; Division of Medical Oncology, Washington University School of Medicine, St. Louis, MO.
Clin Lymphoma Myeloma Leuk ; 18(1): e61-e67, 2018 01.
Article em En | MEDLINE | ID: mdl-29191715
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma de Célula do Manto / Quimioterapia de Indução / Rituximab / Antineoplásicos Imunológicos Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged País como assunto: America do norte Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma de Célula do Manto / Quimioterapia de Indução / Rituximab / Antineoplásicos Imunológicos Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged País como assunto: America do norte Idioma: En Ano de publicação: 2018 Tipo de documento: Article